JRCT ID: jRCT2080223119
Registered date:26/02/2016
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 15/02/2016 |
Target sample size | 1860 |
Countries of recruitment | Asia except Japan,North America,South America,Europe,Africa,null,Japan |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : semaglutide Therapeutic category code : 249 Other hormone preparations (including antihormone preparations) Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | efficacy |
---|---|
Secondary Outcome | safety efficacy |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT02607865,JapicCTI-163174 |
Contact
Public contact | |
Name | |
Address | |
Telephone | - |
JPHC_clinical_trials@novonordisk.com | |
Affiliation | |
Scientific contact | |
Name | |
Address | |
Telephone | - |
JPHC_clinical_trials@novonordisk.com | |
Affiliation |